According to industry experts the MRG authors interviewed, the FDA’s approval process hinders innovation in the U.S. market while driving innovation in the European market — some companies even debut their device abroad to fund FDA trials.
“One prominent example is transcatheter heart valves—the first of these devices became available in Europe in 2007, while approval in the US had not been granted as of Sept. 2011,” the authors wrote.
Related Articles about the Medical Device Industry:
Robotic Surgery Equipment Manufacturing Industry Expected to Reach $4.2B by 2016
Sen. Scott Brown Calls for Repeal of Medical Device Tax
Losses Put Pressure on Medical Device Industry to Lower Prices
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
